Ontera: Paul Marr, John Sperzel

Nanopore sensing and diagnostics company Ontera has appointed Paul Marr as its chief commercial officer and John Sperzel to its board of directors.

Marr has more than 22 years of in vitro diagnostics sales leadership experience that will be critical to the commercialization strategy for Ontera's NanoDetector device, the firm said. Prior to Ontera, he led the US laboratory sales team in providing high-throughput molecular diagnostic testing solutions at Hologic. Previously, he held various sales leadership roles at Beckman Coulter, Leica Biosystems, Siemens, and Ventana Medical Systems.

Sperzel, the president and CEO of T2 Biosystems, was previously president and CEO of Chembio Diagnostics. He was also president and CEO of ITC Medical and held executive leadership positions at Axis-Shield, Bayer Diagnostics, Instrumentation Laboratory, and Boehringer Mannheim.